Antitumor necrosis factor treatment in patients with inflammatory bowel disease does not promote psoriasis development: A meta-analysis.

Yu Kyung JunJoo Young ParkSeong-Joon KohHyunsun ParkHyoun Woo KangJong Pil ImJoo Sung Kim

Published in: Medicine (2022)

Anti-TNF treatment did not contribute to the psoriasis development in patients with IBD. Based on our study, anti-TNF agents may be used for IBD treatment without concern for psoriasis development.

Keyphrases

rheumatoid arthritis
patients with inflammatory bowel disease
atopic dermatitis